Showing results (41-50 of 229) with videos related to

Sort By:
Pageof 23
Current Drug Discovery Technologies|February 14, 2006
Strategies for compound selectionMarius M Olah, Cristian G Bologa, Tudor I Oprea
Methods in Molecular Biology (Clifton, N.J.)|May 5, 2006
Chemical database preparation for compound acquisition or virtual screeningCristian G Bologa, Marius M Olah, Tudor I Oprea
Journal of Molecular Graphics & Modelling|October 20, 2012
Fitting the complexity of GPCRs modulation into simple hypotheses of ligand designChiara Custodi, Roberto Nuti, Tudor I Oprea, et al.
Drug Discovery Today|June 22, 2019
The human endogenous metabolome as a pharmacology baseline for drug discoveryAndreu Bofill, Xavier Jalencas, Tudor I Oprea, et al.
Bioorganic & Medicinal Chemistry|November 13, 2007
2D QSAR and similarity studies on cruzain inhibitors aimed at improving selectivity over cathepsin LRenato F Freitas, Tudor I Oprea, Carlos A Montanari
Molecular Informatics|February 21, 2012
Transporter-mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to TargetFabio Broccatelli, Emanuele Carosati, Gabriele Cruciani, et al.
Journal of Cheminformatics|April 1, 2016
Impact of similarity threshold on the topology of molecular similarity networks and clustering outcomesGergely Zahoránszky-Kőhalmi, Cristian G Bologa, Tudor I Oprea
Journal of Computer-Aided Molecular Design|August 5, 1998
MTD-ADJ: a multiconformational minimal topologic difference for determining bioactive conformers using adjusted biological activitiesT Sulea, L Kurunczi, T I Oprea, et al.
Pageof 23